HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of two atypical PML-RAR(alpha) transcripts in two patients with acute promyelocytic leukemia.

Abstract
We identified two patients with atypical PML-RAR(alpha) rearrangements, 53 and 13 base pairs longer than the typical bcr1 transcript. Sequence analysis revealed a new PML breakpoint at the end of exon 7a in patient 1, and a PML exon 6 breakpoint in patient 2, with an insertion of 35 nucleotides of RAR(alpha) intron 2. Patient 1 did not express RAR(alpha)-PML and patient 2 showed the RAR(alpha)-PML transcript, which corresponded to the typical bcr1. These results emphasize on the relevance of the correct identification of atypical PML-RAR(alpha) rearrangements because of the potential implications in leukemogenesis, in the response to treatment, and for the correct monitoring of minimal residual disease.
AuthorsEva Barragán, Pascual Bolufer, Guillermo Martín, José Cervera, Isabel Moreno, Francisco J Capote, Pedro Rosique, Miguel A Sanz
JournalLeukemia research (Leuk Res) Vol. 26 Issue 5 Pg. 439-42 (May 2002) ISSN: 0145-2126 [Print] England
PMID11916515 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Neoplasm Proteins
  • Oncogene Proteins, Fusion
  • RNA, Messenger
  • promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
Topics
  • Adult
  • Base Sequence
  • Gene Rearrangement
  • Humans
  • Leukemia, Promyelocytic, Acute (genetics)
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Neoplasm Proteins (genetics)
  • Oncogene Proteins, Fusion (genetics)
  • RNA, Messenger (analysis)
  • Reverse Transcriptase Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: